Home / Topics / biotechnology

biotechnology Podcasts

21 episodes about biotechnology

Novo Nordisk A/S (NVO) Announced Q2 2026 Earnings on August 5, 2026, Reporting "adjusted sales increased by 7% at constant exchange rates, reaching DKK 78.5 billion" for the Quarter artwork

Novo Nordisk A/S (NVO) Announced Q2 2026 Earnings on August 5, 2026, Reporting "adjusted sales increased by 7% at constant exchange rates, reaching DKK 78.5 billion" for the Quarter
Novo Nordisk A/S (NVO)
• 22:17 •Ep 229 •The Earnings Debate
Novo Nordisk A/S Announced Q1 2026 Earnings on May 6, 2026, Reporting "reported sales increased by 32%, reaching DKK 96.8 billion" for the quarter. artwork

Novo Nordisk A/S Announced Q1 2026 Earnings on May 6, 2026, Reporting "reported sales increased by 32%, reaching DKK 96.8 billion" for the quarter.
Novo Nordisk A/S (NVO)
• 19:53 •Ep 165 •The Earnings Debate •▶ Play on Apple
Ginkgo Bioworks Holdings, Inc. Announced Q1 2026 Earnings on May 7, 2026, Reporting "Revenue was $19 million in the first quarter of 2026" artwork

Ginkgo Bioworks Holdings, Inc. Announced Q1 2026 Earnings on May 7, 2026, Reporting "Revenue was $19 million in the first quarter of 2026"
Ginkgo Bioworks Holdings Inc. (DNA)
• 21:25 •Ep 152 •The Earnings Debate •▶ Play on Apple
BeOne Medicines AG Announced Q1 2026 Earnings on May 6, 2026, Reporting "Product revenue reached $1.5 billion in the quarter" artwork

BeOne Medicines AG Announced Q1 2026 Earnings on May 6, 2026, Reporting "Product revenue reached $1.5 billion in the quarter"
BeOne Medicines AG (ONC)
• 20:59 •Ep 149 •The Earnings Debate •▶ Play on Apple
Rhythm Pharmaceuticals, Inc. (RYTM) Announced Q1 2026 Earnings on May 5, 2026, Reporting "Revenues for the quarter were $60 million." artwork

Rhythm Pharmaceuticals, Inc. (RYTM) Announced Q1 2026 Earnings on May 5, 2026, Reporting "Revenues for the quarter were $60 million."
Rhythm Pharmaceuticals Inc. (RYTM)
• 17:56 •Ep 146 •The Earnings Debate •▶ Play on Apple
Moderna, Inc. (MRNA) Announced Q1 2026 Earnings on May 1, 2026, Reporting "total revenue was $400 million". artwork

Moderna, Inc. (MRNA) Announced Q1 2026 Earnings on May 1, 2026, Reporting "total revenue was $400 million".
Moderna Inc. (MRNA)
• 19:08 •Ep 142 •The Earnings Debate •▶ Play on Apple
Amgen Inc. (AMGN) Announced Q1 2026 Earnings on April 30, 2026, Reporting "4% growth in product sales" artwork

Amgen Inc. (AMGN) Announced Q1 2026 Earnings on April 30, 2026, Reporting "4% growth in product sales"
Amgen Inc. (AMGN)
• 22:12 •Ep 123 •The Earnings Debate •▶ Play on Apple
Illumina, Inc. (ILMN) Announced Q1 2026 Earnings on April 30, 2026, Reporting "revenue of $1.09 billion". artwork

Illumina, Inc. (ILMN) Announced Q1 2026 Earnings on April 30, 2026, Reporting "revenue of $1.09 billion".
Illumina Inc. (ILMN)
• 19:33 •Ep 124 •The Earnings Debate •▶ Play on Apple
Eli Lilly and Company Announced Q1 2026 Earnings on April 30, 2026, Reporting Revenue grew 56% compared to Q1 2 artwork

Eli Lilly and Company Announced Q1 2026 Earnings on April 30, 2026, Reporting Revenue grew 56% compared to Q1 2
Eli Lilly and Company (LLY)
• 22:36 •Ep 118 •The Earnings Debate •▶ Play on Apple
Viking Therapeutics, Inc. Announced Q1 2026 Earnings on April 29, 2026, Reporting "a net loss of $158.3 million or $1.37 per share" artwork

Viking Therapeutics, Inc. Announced Q1 2026 Earnings on April 29, 2026, Reporting "a net loss of $158.3 million or $1.37 per share"
Viking Therapeutics Inc. (VKTX)
• 20:54 •Ep 113 •The Earnings Debate •▶ Play on Apple
AbbVie Inc. Announced Q1 2026 Earnings on April 29, 2026, Reporting "Total net revenues were $15 billion beating our expectations by $300 million and reflecting robust sales growth of 12.4%." artwork

AbbVie Inc. Announced Q1 2026 Earnings on April 29, 2026, Reporting "Total net revenues were $15 billion beating our expectations by $300 million and reflecting robust sales growth of 12.4%."
AbbVie Inc. (ABBV)
• 15:24 •Ep 111 •The Earnings Debate •▶ Play on Apple
AstraZeneca PLC (AZN) Announced Q1 2026 Earnings on April 29, 2026, Reporting "Total revenue grew 8% in the quarter". artwork

AstraZeneca PLC (AZN) Announced Q1 2026 Earnings on April 29, 2026, Reporting "Total revenue grew 8% in the quarter".
AstraZeneca PLC (AZN)
• 13:58 •Ep 110 •The Earnings Debate •▶ Play on Apple
Novartis AG (NVS) Announced Q1 2026 Earnings on April 28, 2026, Reporting "sales down 5% and core op inc down 14%" artwork

Novartis AG (NVS) Announced Q1 2026 Earnings on April 28, 2026, Reporting "sales down 5% and core op inc down 14%"
Novartis AG (NVS)
• 18:36 •Ep 100 •The Earnings Debate •▶ Play on Apple
Inside Gilead Sciences: Leading in virology while diversifying into oncology and inflammation artwork

Inside Gilead Sciences: Leading in virology while diversifying into oncology and inflammation
Gilead Sciences Inc. (GILD)
• 48:38 •Ep 17 •Inside the Business •▶ Play on Apple
Gilead Sciences Tech Radar: Acquiring in vivo cell therapy platforms to reduce costs artwork

Gilead Sciences Tech Radar: Acquiring in vivo cell therapy platforms to reduce costs
Gilead Sciences Inc. (GILD)
• 18:51 •Ep 14 •Business Tech Radar •▶ Play on Apple
Inside Amgen: A biologics leader driving volume growth through cardiometabolic and rare disease innovation artwork

Inside Amgen: A biologics leader driving volume growth through cardiometabolic and rare disease innovation
Amgen (AMGN)
• 29:06 •Ep 13 •Inside the Business •▶ Play on Apple
Amgen Tech Radar: Amgen is deploying artificial intelligence to accelerate therapeutic discovery artwork

Amgen Tech Radar: Amgen is deploying artificial intelligence to accelerate therapeutic discovery
Amgen (AMGN)
• 20:22 •Ep 10 •Business Tech Radar •▶ Play on Apple
ImmunityBio, Inc. Announced Full Year 2025 Earnings on March 3, 2026, Reporting "Full year net product revenue for ANKTIVA was $113 million" artwork

ImmunityBio, Inc. Announced Full Year 2025 Earnings on March 3, 2026, Reporting "Full year net product revenue for ANKTIVA was $113 million"
ImmunityBio Inc. (IBRX)
• 18:00 •Ep 51 •The Earnings Debate •▶ Play on Apple
Natera, Inc. (NTRA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "roughly $666 million of revenue in the quarter" artwork

Natera, Inc. (NTRA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "roughly $666 million of revenue in the quarter"
Natera Inc. (NTRA)
• 10:22 •Ep 43 •The Earnings Debate •▶ Play on Apple
Ginkgo Bioworks Holdings, Inc. (DNA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "Cell engineering revenue was $26 million in the fourth quarter of 2025" artwork

Ginkgo Bioworks Holdings, Inc. (DNA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "Cell engineering revenue was $26 million in the fourth quarter of 2025"
Ginkgo Bioworks Holdings Inc. (DNA)
• 17:11 •Ep 41 •The Earnings Debate •▶ Play on Apple
BeOne Medicines AG Announced Q4 2025 Earnings on February 26, 2026, Reporting "Product revenue reached $1.5 billion in the fourth quarter". artwork

BeOne Medicines AG Announced Q4 2025 Earnings on February 26, 2026, Reporting "Product revenue reached $1.5 billion in the fourth quarter".
BeOne Medicines AG (ONC)
• 10:46 •Ep 37 •The Earnings Debate •▶ Play on Apple